News
October 10, 2023
XXIV FIGO World Congress – Championing Maternal Health: Nobel Prize-Winning Discoveries Transforming Preeclampsia
Learn More
August 28, 2023
Comanche Biopharma Named by Fierce Biotech as a “Fierce 15” Biotech Company of 2023
August 23, 2023
Comanche Biopharma Receives US FDA Fast Track Designation for CBP-4888 for the Treatment of sFlt-1 mediated pre-term preeclampsia
June 13, 2023
Comanche Biopharma Strengthens Board of Directors with Appointment of Dr. Ann Taylor
March 30, 2023
Comanche Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for CBP-4888, an siRNA Investigational Therapy for the Treatment of Preeclampsia
December 15, 2022
Comanche Biopharma Announces Appointment of Allison August, M.D., as Chief Medical Officer
Media Contact
Jove Oliver
Oliver Global Communications
Mob: +1 646 373 4702
Email: press@comanchebiopharma.com
Learn More
Contact Us
50 Beharrell St, Unit B
Concord, MA 01742